To determine whether the p63/Her2/neu expressing cells represent a subgroup that is unique to comedo-DCIS, we performed similar immunofluorescence double labeling analysis of p63 and Her2/neu in tumors generated from SUM225 human breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.